Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Transplant Toxicities

Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children

Abstract

Hepatic focal nodular hyperplasia (FNH) is a nonmalignant condition rarely affecting children previously treated for cancer, especially those who received hematopoietic SCT (HSCT). Some aspects of its pathogenesis still remain unclear and a strong association with specific risk factors has not yet been identified. We report here a single institution's case series of 17 patients who underwent HSCT and were diagnosed with FNH, analyzing retrospectively their clinical features and the radiological appearance of their hepatic lesions. We aimed to compare the diagnostic accuracy of ultrasound (US) and magnetic resonance imaging (MRI) and to explore the role of transient elastography (FibroScan) to evaluate the degree of hepatic fibrosis in FNH patients. Our analysis showed an association of FNH with age at transplant 12 years (hazard ratio (HR) 9.10); chronic GVHD (HR 2.99); hormone-replacement therapy (HR 4.02) and abdominal radiotherapy (HR 4.37). MRI proved to be a more accurate diagnostic tool compared with US. Nine out of 12 patients who underwent FibroScan showed hepatic fibrosis. Our study points out that FNH is an emerging complication of HSCT, which requires a lifelong surveillance to follow its course in cancer patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Pezzullo L, Muretto P, De Rosa G, Picardi M, Lucania A, Rotoli B . Liver nodular regenerative hyperplasia after bone marrow transplant. Hematologica 2000; 85: 669–670.

    CAS  Google Scholar 

  2. De Bouyn CI, Leclere J, Raimondo G, Ducou le Pointe H, Couanet D, Valteau-Couanet D et al. Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 2003; 97: 3107–3113.

    Article  Google Scholar 

  3. Masetti R, Biagi C, Kleinschmidt K, Prete A, Baronio F, Colecchia A et al. Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor? Eur J Pediatr 2011; 170: 807–812.

    Article  Google Scholar 

  4. Masetti R, Colecchia A, Rondelli R, Martoni A, Vendemini F, Biagi C et al. Benign hepatic nodular lesions after treatment for childhood cancer. J Pediatr Gastroenterol Nutr 2013; 56: 151–155.

    Article  CAS  Google Scholar 

  5. Sudour H, Mainard L, Baumann C, Clement L, Salmon A, Bordigoni P . Focal nodular hyperplasia of the liver following hematopoietic SCT. Bone Marrow Transplant 2008; 43: 127–132.

    Article  Google Scholar 

  6. Smith EA, Salisbury S, Martin R, Twbin AJ . Incidence and etiology of new liver lesions in pediatric patients previously treated for malignancy. Am J Roentgenol 2012; 199: 186–191.

    Article  Google Scholar 

  7. Masetti R, Zama D, Gasperini P, Morello W, Prete A, Colecchia A et al. Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation. Pediatr Transplant 2013; 17: 479–486.

    Article  Google Scholar 

  8. Gobbi D, Dall’Igna P, Messina C, Cesca E, Cecchetto G . Focal nodular hyperplasia in pediatric patients with and without oncologic history. Pediatr Blood Cancer 2010; 55: 1420–1422.

    Article  Google Scholar 

  9. Kondo F, Nagao T, Sato T, Tomizawa M, Kondo Y, Matsuzaki O et al. Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension. Pathol Res Pract 1998; 194: 487–495.

    Article  CAS  Google Scholar 

  10. Craig JR, Peters RL, Edmondson HA, Omata M . Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980; 46: 372–379.

    Article  CAS  Google Scholar 

  11. Vanzulli A, Morana G, Grazioli L, SIRM RM Addominale. Poletto, Milano, 2014.

    Google Scholar 

  12. Attal P, Vilgrain V, Brancatelli G, Paradis V, Terris B, Belghiti J et al. Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases. Radiology 2003; 228: 465–472.

    Article  Google Scholar 

  13. Fowler KJ, Brown JJ, Narra VR . Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis. Hepatology 2011; 54: 2227–2237.

    Article  Google Scholar 

  14. Ronot M ., Vilgrain V . Imaging of benign hepatocellular lesions: current concept and recent updates. Clin Res Hepatol Gastroenterol 2014; 38: 681–688.

    Article  Google Scholar 

  15. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705–1713.

    Article  Google Scholar 

  16. Konate A, Reaud S, Quenemer E, Fouchard-Hubert I, Oberti F, Cales P . Liver stiffness measurement by transient elastography: predictive factors of accuracy and reproducibility. J Hepatol 2006; 44: 195.

    Article  Google Scholar 

  17. Peto R, Pet J . Asymptotically efficient rank invariant test procedures. J R Stat Soc A 1972; 135: 185–198.

    Article  Google Scholar 

  18. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J . Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 2008; 48: 163–170.

    Article  CAS  Google Scholar 

  19. Rebouissou S, Couchy G, Libbrecht L, Balbaud C, Imbeaud S, Auffray C et al. The β-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 2008; 49: 61–71.

    Article  CAS  Google Scholar 

  20. Wanless IR, Mawdsley C, Adams R . On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5: 1194–1200.

    Article  CAS  Google Scholar 

  21. Anderson L, Gregg D, Margolis D, Casper J, Talano J . Focal nodular hyperplasia in pediatric hematopoietc allogeneic cell transplant: case series. Bone Marrow Transplant 2010; 45: 1357–1359.

    Article  CAS  Google Scholar 

  22. Marabelle A, Campagna D, Déchelotte P, Chipponi J, Deméocq F, Kanold J . Focal nodular hyperplasia of the liver in patients previously treated for pediatric neolplastic diseases. J Pediatr Hematol Oncol 2008; 30: 546–549.

    Article  Google Scholar 

  23. Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrel L, Hernandez-Prera JC et al. Focal nodular hyperplasia and hepatocellular adenoma around the world viewed through the scope of the immunopathological classification. Int J Hepatol 2013; 2013: 268625.

    Article  Google Scholar 

  24. Nguyen BN, Flèjou JF, Terris B, Belghiti J, Degott C . Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999; 23: 1441–1454.

    Article  CAS  Google Scholar 

  25. Stoot JH, Coelen RJ, De Jong MC, Dejong CH . Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB 2010; 12: 509–522.

    Article  Google Scholar 

  26. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983–993.

    Article  Google Scholar 

  27. Wanless IR, Gryfe A . Nodular transformation of the liver in hereditary hemorragic telangectasia. Arch Pathol Lab Med 1986; 110: 331–335.

    CAS  PubMed  Google Scholar 

  28. Mathieu D, Kobeiter H, Maison P . Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 2000; 118: 560–564.

    Article  CAS  Google Scholar 

  29. Giannitrapani L, Soresi M, La Spada A, Cervello M, D’Alessandro N, Montalto G . Sex hormones and risk of liver tumor. Ann NY Acad Sci 2006; 1089: 228–236.

    Article  CAS  Google Scholar 

  30. La Vecchia C, Tavani A . Female hormones and benign liver tumours. Digest Liver Dis 2006; 38: 535–536.

    Article  CAS  Google Scholar 

  31. Kapp N, Curtis KM . Hormonal contraceptive use among women with liver tumors: a systematic review. Contraception 2009; 80: 387–390.

    Article  CAS  Google Scholar 

  32. Farruggia P, Alaggio R, Cardella F, Tropia S, Trizzino A, Ferrara F et al. Focal nodular hyperplasia of the liver: an unusual association with diabetes mellitus in a child and review of literature. Ital J Pediatr 2010; 36: 41.

    Article  Google Scholar 

  33. Valentino PL, Ling SC, Ng VL, John P, Bonasoni P, Castro DA et al. The role of diagnostic imaging and liver biopsy in the diagnosis of focal nodular hyperplasia in children. Liver Int 2013; 34: 227–234.

    Article  Google Scholar 

  34. Shamsi K, De Schepper A, Degryse H, Deckers F . Focal nodular hyperplasia of the liver: radiologic findings. Abdom Imaging 1993; 18: 32–38.

    Article  CAS  Google Scholar 

  35. Buetow PC, Pantongrag-Brown L, Buck JL, Ros PR, Goodman ZD . Focal nodular hyperplasia of the liver: radiologic-pathologic correlation. Radiographics 1996; 16: 369–388.

    Article  CAS  Google Scholar 

  36. Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Métreau JM, Meignan M et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 1995; 22: 1674–1681.

    Article  CAS  Google Scholar 

  37. Quaia E . The real capabilities of contrast-enhanced ultrasound in the characterization of solid focal liver lesions. Eur Radiol 2011; 21: 457–462.

    Article  Google Scholar 

  38. Frulio N, Laumonier H, Carteret T, Laurent C, Maire F, Balabaud C et al. Evaluation of liver tumors using acoustic radiation force impulse Elastography and correlation with histologic data. J Ultrasound Med 2013; 32: 121–130.

    Article  Google Scholar 

  39. Eckersley-Maslin MA, Warner FJ, Grzelak CA, McCaughan GW, Shackel NA . Bone marrow stem cells and the liver: are they relevant? J Gastroenterol Hepatol 2009; 24: 1608–1616.

    Article  Google Scholar 

  40. Flemming P, Tillmann HL, Barg-Hock H, Kleeberger W, Manns MP, Klempnauer J et al. Donor origin of de novo hepatocellular carcinoma in hepatic allografts. Transplantation 2003; 76: 1625–1627.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Messina.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pillon, M., Carucci, N., Mainardi, C. et al. Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children. Bone Marrow Transplant 50, 414–419 (2015). https://doi.org/10.1038/bmt.2014.276

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2014.276

This article is cited by

Search

Quick links